SFM
PVLA

Sphera Funds Management’s Palvella Therapeutics PVLA Stock Holding History

Sphera Funds Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,125
Closed -$1.67M – 172
2021
Q1 		$1.67M Buy
8,125
+1,250
+18% +$273K 0.13% 118
2020
Q4 		$1.38M Buy
+6,875
New +$1.43M 0.12% 93
2019
Q1 		– Sell
-8,750
Closed -$1.86M – 124
2018
Q4 		$1.86M Sell
8,750
-2,559
-23% -$794K 0.21% 78
2018
Q3 		$5.07M Buy
11,309
+776
+7% +$337K 0.58% 46
2018
Q2 		$4.27M Buy
10,533
+533
+5% +$254K 0.59% 51
2018
Q1 		$5.46M Hold
10,000
– – 0.83% 37
2017
Q4 		$6.04M Sell
10,000
-2,500
-20% -$1.16M 0.71% 30
2017
Q3 		$5.76M Sell
12,500
-1,250
-9% -$534K 0.82% 27
2017
Q2 		$5.57M Buy
13,750
+1,250
+10% +$365K 0.95% 26
2017
Q1 		$2.6M Buy
12,500
+2,375
+23% +$420K 0.51% 57
2016
Q4 		$1.13M Hold
10,125
– – 0.29% 80
2016
Q3 		$1.48M Hold
10,125
– – 0.24% 85
2016
Q2 		$1.3M Hold
10,125
– – 0.34% 71
2016
Q1 		$1.54M Hold
10,125
– – 0.33% 69
2015
Q4 		$1.85M Sell
10,125
-1,125
-10% -$189K 0.27% 90
2015
Q3 		$1.65M Sell
11,250
-3,750
-25% -$837K 0.21% 104
2015
Q2 		$3.3M Buy
+15,000
New +$3.3M 0.32% 76

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Sphera Funds Management's PVLA Position: Q2 2021 in Review

Sphera Funds Management sold out of Palvella Therapeutics (PVLA) in Q2 2021, closing a stake of 8,125 shares — an estimated $1.67M sold.

Sphera Funds Management first reported a position in PVLA in Q2 2015 and held it in 17 quarters. The position peaked at $6.04M in Q4 2017. 73 funds tracked by Wall St. Rank hold PVLA as of Q2 2021.

  • Sphera Funds Management reported no remaining Palvella Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Sphera Funds Management sold 8,125 Palvella Therapeutics shares in Q2 2021, an estimated $1.67M.
  • Sphera Funds Management first reported a position in Palvella Therapeutics in Q2 2015 and held it in 17 quarters.
  • Sphera Funds Management's Palvella Therapeutics position peaked at $6.04M in Q4 2017.
  • 73 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2021.

Based on Sphera Funds Management's 13F filing for Q2 2021, filed 17 Aug 2021.